Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 29 10 2020
accepted: 07 01 2021
entrez: 18 2 2021
pubmed: 19 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Pathogenesis of cytokine storm is poorly understood. In this article we propose a new mechanism and suggest innovative therapeutic avenues for its prevention. We have reported that particles of cell-free chromatin (cfCh) that are released from the billions of cells that die in the body everyday can illegitimately integrate into genomes of healthy cells to trigger dsDNA breaks. The latter leads to apoptosis and/or intense activation of inflammatory cytokines in the affected cells. We hypothesise that a similar phenomenon of dsDNA breaks and inflammation is involved in cytokine storm. The abundant cfCh particles that are released from dying host cells following viral/microbial invasion initiate a cascading effect of more cell death resulting in a vicious cycle of further DNA damage, apoptosis and hyper-inflammation which culminate in cytokine storm. We propose that this unrelenting vicious cycle of cellular DNA damage and cytokine storm may be the underlying cause of high mortality from severe COVID-19. We discuss results of our preclinical studies wherein we have shown that endotoxin induced cytokine storm in mice can be reversed by three different agents that have the ability to inactivate cfCh. These agents may be worthy of investigation in clinical trials to reduce mortality from COVID-19.

Identifiants

pubmed: 33597956
doi: 10.3389/fimmu.2021.622738
pmc: PMC7882731
doi:

Substances chimiques

Endotoxins 0
Free Radicals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

622738

Informations de copyright

Copyright © 2021 Shabrish and Mittra.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Immune Netw. 2018 Aug 13;18(4):e27
pubmed: 30181915
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a000745
pubmed: 20980439
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000067
pubmed: 20066093
Front Immunol. 2015 Aug 18;6:422
pubmed: 26347745
Ann N Y Acad Sci. 2006 Sep;1075:318-27
pubmed: 17108227
Nat Genet. 2012 May 06;44(6):642-50
pubmed: 22561516
Genes (Basel). 2019 May 28;10(6):
pubmed: 31142004
Clin Exp Immunol. 1999 Aug;117(2):403-11
pubmed: 10444277
Nature. 2015 Apr 23;520(7548):553-7
pubmed: 25642965
J Biosci. 2015 Mar;40(1):91-111
pubmed: 25740145
Sci Signal. 2011 Jan 18;4(156):pe2
pubmed: 21245467
J Med Virol. 2005 Feb;75(2):185-94
pubmed: 15602737
Mutat Res. 2018 Mar;808:48-52
pubmed: 29518635
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4612-E4620
pubmed: 28533362
Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):147-51
pubmed: 23104849
Cell Death Dis. 2016 Dec 8;7(12):e2518
pubmed: 27929534
Cell Death Dis. 2018 Nov 15;9(12):1142
pubmed: 30442925
Clin Immunol. 2017 Oct;183:254-262
pubmed: 28863968
Cytogenet Cell Genet. 1997;76(1-2):53-7
pubmed: 9154128
J Biol Chem. 2014 Dec 19;289(51):35237-45
pubmed: 25391648
Crit Care Med. 2020 Dec;48(12):1841-1844
pubmed: 32826431
Am J Hum Genet. 2016 Jun 2;98(6):1208-1219
pubmed: 27231129
Mol Genet Genomics. 2016 Apr;291(2):513-30
pubmed: 26481646
Cell Res. 2019 May;29(5):347-364
pubmed: 30948788
Curr Opin Cardiol. 2017 May;32(3):267-274
pubmed: 28169948
J Exp Med. 2018 May 7;215(5):1287-1299
pubmed: 29622565
Int J Infect Dis. 2012 Jul;16(7):e558-64
pubmed: 22609014
N Engl J Med. 2003 Jan 9;348(2):138-50
pubmed: 12519925
Bone. 2015 Sep;78:81-6
pubmed: 25952970
Oncogene. 1999 Nov 22;18(49):6853-66
pubmed: 10602461
Immunity. 2013 May 23;38(5):870-80
pubmed: 23706668
Clin Chem. 2005 Aug;51(8):1544-6
pubmed: 16040855
Cell. 2020 Oct 1;183(1):143-157.e13
pubmed: 32877699
Nat Rev Endocrinol. 2021 Jan;17(1):11-30
pubmed: 33188364
Immunity. 2015 Feb 17;42(2):332-343
pubmed: 25692705
J Biosci. 2019 Jun;44(2):
pubmed: 31180045
J Immunother Cancer. 2018 Jan 03;6(1):1
pubmed: 29298730
Eur J Trauma Emerg Surg. 2020 Aug;46(4):751-775
pubmed: 31612270
Ann N Y Acad Sci. 2008 Aug;1137:180-9
pubmed: 18837945
Am J Hum Genet. 2012 Feb 10;90(2):217-28
pubmed: 22305530
Science. 2003 Nov 28;302(5650):1516-7
pubmed: 14645835
Front Immunol. 2019 Oct 30;10:2536
pubmed: 31736963
Cell Metab. 2015 Jun 2;21(6):793-4
pubmed: 26039443
Science. 2002 Apr 12;296(5566):301-5
pubmed: 11951032
Clin Chim Acta. 2008 Jan;387(1-2):55-8
pubmed: 17916343
Semin Radiat Oncol. 2015 Jan;25(1):4-10
pubmed: 25481260
J Clin Invest. 1990 Jul;86(1):69-74
pubmed: 2365827
Ann N Y Acad Sci. 2006 Sep;1075:191-6
pubmed: 17108211
J Immunol. 1996 Feb 1;156(3):1151-6
pubmed: 8557992
Ann Rheum Dis. 2003 Jan;62(1):10-4
pubmed: 12480662
Cell Death Dis. 2013 May 16;4:e631
pubmed: 23681226
Ann N Y Acad Sci. 2006 Sep;1075:258-70
pubmed: 17108219
Ann Oncol. 2017 Sep 1;28(9):2119-2127
pubmed: 28911066
PLoS One. 2013 Aug 20;8(8):e72834
pubmed: 23977360
Sci Rep. 2019 Sep 20;9(1):13648
pubmed: 31541163
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620950825
pubmed: 32833555
Cell Death Discov. 2017 May 29;3:17015
pubmed: 28580170
Semin Immunopathol. 2017 Jul;39(5):517-528
pubmed: 28555385
Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250
pubmed: 32247212
Immune Netw. 2020 Jun 22;20(3):e23
pubmed: 32655971
PLoS One. 2020 Mar 4;15(3):e0229017
pubmed: 32130239
J Thorac Dis. 2016 Jul;8(7):1406-9
pubmed: 27500853
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
Genome Res. 2017 Oct;27(10):1704-1714
pubmed: 28855261
Nat Cell Biol. 2017 Sep;19(9):1061-1070
pubmed: 28759028
Neurol Neurochir Pol. 2003 Mar-Apr;37(2):315-26
pubmed: 14558480
Surg Infect (Larchmt). 2018 Feb/Mar;19(2):107-116
pubmed: 29364781
Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32
pubmed: 22390970
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Crit Care Med. 2010 Apr;38(4 Suppl):e10-20
pubmed: 20048675
J Mol Med (Berl). 2014 May;92(5):465-72
pubmed: 24706102
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Exp Gerontol. 2015 Sep;69:70-8
pubmed: 26026597
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Front Immunol. 2019 Jun 14;10:1346
pubmed: 31258530
J Cell Physiol. 2016 Jan;231(1):15-24
pubmed: 26033759
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
Crit Care Med. 2003 Jul;31(7):1947-51
pubmed: 12847387
Oncotarget. 2020 Jan 21;11(3):213-215
pubmed: 32076483
J Biosci. 2012 Jun;37(2):301-12
pubmed: 22581336
Int Anesthesiol Clin. 2007 Spring;45(2):27-37
pubmed: 17426506
Br J Cancer. 1972 Aug;26(4):239-57
pubmed: 4561027
Cell Death Dis. 2017 May 25;8(5):e2812
pubmed: 28542146
Cerebrovasc Dis. 2006;21(1-2):32-7
pubmed: 16282687
Front Pharmacol. 2020 Oct 16;11:563478
pubmed: 33178016
Semin Immunopathol. 2017 Jul;39(5):541-550
pubmed: 28555383
Cell Mol Immunol. 2016 Jan;13(1):3-10
pubmed: 26189369
Clin Chem. 2007 Dec;53(12):2215
pubmed: 18267930
Clin Chem Lab Med. 2001 Jul;39(7):596-605
pubmed: 11522104
J Thromb Haemost. 2015 Jun;13 Suppl 1:S82-91
pubmed: 26149054
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S3-23
pubmed: 20176265
BMC Pediatr. 2018 Aug 9;18(1):267
pubmed: 30092777
J Cell Biol. 2013 Jul 8;202(1):129-43
pubmed: 23816621
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-2040
pubmed: 23818485
Shock. 2013 Jan;39(1):113-4
pubmed: 23247128
Mol Med. 2011 Jan-Feb;17(1-2):2-3
pubmed: 21246163
Nature. 2017 Oct 19;550(7676):402-406
pubmed: 28976970
Sultan Qaboos Univ Med J. 2015 Feb;15(1):e9-e21
pubmed: 25685392

Auteurs

Snehal Shabrish (S)

Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, and Homi Bhabha National Institute, Mumbai, India.

Indraneel Mittra (I)

Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, and Homi Bhabha National Institute, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH